# Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

> **NCT00675831** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 24 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DEVICE:** CliniMACS CD25 Reagent Device

## Key facts

- **NCT ID:** NCT00675831
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675831, "Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00675831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*